Crestline Management, LP Bristol Myers Squibb CO Transaction History

Crestline Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $3.29 Million - $3.9 Million	-77,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $3.44 Million - $3.8 Million	77,000 New	77,000 $3.49 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $3.54 Million - $4 Million	-64,224 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $957,038 - $1.19 Million	18,940 Added 41.82%	64,224 $3.55 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $419,739 - $483,204	-7,005 Reduced 13.4%	45,284 $2.86 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $712,626 - $776,946	11,889 Added 29.43%	52,289 $3.2 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $2.23 Million - $2.58 Million	40,400	40,400 $2.58 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.